532
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Protective activity of Jiang-Zhi-Li-Gan against carbon tetrachloride-induced hepatic injury in mice

Pages 231-233 | Received 23 Feb 2009, Accepted 08 May 2009, Published online: 25 Jan 2010

Abstract

The administration of carbon tetrachloride (CCl4) to mice produced hepatotoxicity, showing a significant increase in the serum levels of alanine transaminase (ALT) and aspartate aminotransferase (AST). Mice pretreated with Jiang-Zhi-Li-Gan (JZLG, 100–900 mg/kg, p.o.), a domestic remedy for liver disease in Rui-Jin Hospital, showed a significant decrease in serum ALT and AST levels when compared to the group treated with CCl4 alone. The standard drug, bifendate (200 mg/kg, p.o.), also exhibited similar results. In the acute toxicity study, JZLG did not show any mortality up to a dose of 32 g/kg body weight. Based on the results obtained, it can be concluded that JZLG seems to possess hepatoprotective activity in mice. These results support the use of this prescription against chemical hepatic injury.

Introduction

Jiang-Zhi-Li-Gan (JZLG) comprises: (1) Radix Bupleuri (Umbelliferae), the dried roots of Bupleurum chinense DC. or Bulpeurum scorzoneri folium Willd., used for treatment of liver disease in oriental medicine and possessing anti-tumor properties (CitationKang et al., 2008); (2) Radix Astragali (Leguminosae), the dried roots of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao or Astragalus membranaceus (Fisch.) Bge., widely used for treatment of cardiovascular diseases such as heart failure, angina pectoris, myocardial infarction, and stroke in Asian countries (CitationZhao et al., 2008); (3) Fructus Crataegi (Rosaceae), the dried matured fruits of Crataegus pinnatifida Bge. var. major N.E. Br. or Crataegus pinnatifida Bge., possessing potential against oxidative stress (CitationChu et al., 2003); (4) Radix et Rhizoma Salviae Miltiorrhizae (Labiatae), the dried roots and rhizome of Salvia miltiorrhiza Bge. or Salviae miltiorrhizae Radix (SMR), an eminent herb in the treatment of cardiovascular disorder (called blood stasis in traditional Chinese medicine) widely used in China, Japan, Taiwan, and Korea (CitationKoo et al., 2004); (5) Radix et Rhizoma Rhei (Polyginaceae), the dried roots and rhizome of Rheum palmatum L., Rheum tanguticum Maxim. ex Balf., or Rheum officinale Baill., having a protective capacity both in vitro on primary hepatocyte cultures and in in vivo in a rat model of CCl4 mediated liver injury (CitationIbrahim et al., 2008); and (6) Radix et Rhizoma Glycyrrhizae (Leguminosae), the dried roots and rhizome of Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat., or Glycyrrhiza glabra L., having long been used worldwide as a herbal medicine and natural sweetener and as a traditional medicine mainly for the treatment of peptic ulcer, hepatitis C, and pulmonary and skin diseases (CitationAsl & Hosseinzadeh, 2008). This prescription is a remedy for liver disease that has been used in Rui-Jin Hospital for years. However, its effect on carbon tetrachloride (CCl4) induced liver injury has never been investigated.

The present study was designed to investigate the effect of JZLG on acute chemical liver injury by CCl4 in mice.

Materials and methods

Plants

Air-dried plants were supplied by Shanghai Herbal Medicine Co. Ltd. (Shanghai, China). A voucher specimen of each plant is deposited in the Department of Pharmacy, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (reference number 080413:1–6).

Reagents

Alanine transaminase (ALT) and aspartate aminotransferase (AST) assay kits were purchased from Kang-Jian (Shanghai, China). Other chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated.

Extraction

Deionized water (1 L) was added to 100.0 g of JZLG prescription, comprising 12.8 g of Radix Bupleuri, 19.2 g of Radix Astragali, 25.6 g of Fructus Crataegi, 19.2 g of Radix et Rhizoma Salviae Miltiorrhizae, 3.8 g of Radix et Rhizoma Rhei, and 19.4 g of Radix et Rhizoma Glycyrrhizae, previously ground and sieved through a mesh No. 50, and was heated until the preparation boiled. Boiling was continued for 2 h. The decoction was then percolated to obtain the filtrate, and the dregs were re-boiled with fresh deionized water (1 L) for 1 h. Collected filtrates were then poured together and evaporated in a vacuum to give a dark brown semi-solid extract (yield 32.2%), which was stored at −20°C until use.

Animals

Kun-Ming mice of either sex (weighing 19–21 g) were supplied by Shanghai Slac Laboratory Animal Co. Ltd. (Shanghai, China). The mice were housed in cages under controlled conditions at 20 ± 3°C and 45–65% humidity with a 12 h light–dark cycle (lights on 6:00 h). Drinking water and food were provided ad libitum throughout the study. Animals were acclimatized to their environment for 1 week prior to experimentation. All procedures were performed in accordance with guidelines on the care and use of experimental animals set by Fudan University Cancer Hospital.

Hepatoprotective activity

Hepatic injury was induced in mice by intraperitoneal administration of a single dose of 10 mL/kg 0.1% CCl4. Bifendate (biphenyldicarboxylate), a known hepatoprotective agent, was used as the reference standard (CitationPan et al., 2006).

The 60 mice were grouped randomly as follows:

  • Group I: Control group, treated with vehicle (0.2 mL, p.o.) daily for 7 days.

  • Group II: Treated with vehicle (0.2 mL, p.o.) daily for 7 days followed by CCl4 on day 7.

  • Group III: Treated with low dose of JZLG (100 mg/kg, p.o.) daily for 7 days followed by CCl4 on day 7.

  • Group IV: Treated with medium dose of JZLG (300 mg/kg, p.o.) daily for 7 days followed by CCl4 on day 7.

  • Group V: Treated with high dose of JZLG (900 mg/kg, p.o.) daily for 7 days followed by CCl4 on day 7.

  • Group VI: Treated with bifendate (200 mg/kg, p.o.) daily for 7 days followed by CCl4 on day 7.

At the end of the treatment, body weight and relative liver weight were measured; blood samples of each animal were collected in sterile centrifuge tubes and allowed to clot. The serum was separated and used for the assay of marker enzymes (ALT and AST).

Acute toxicity study

Mice were divided into groups of 10 animals each. The control group received saline and the other groups received increasing doses of JZLG extract, respectively. Immediately after dosing, the animals were observed continuously for 7 days to record the mortality.

Statistical analysis

Group mean values and standard deviations were calculated. Data are expressed as mean ± SD. Statistically significant differences were determined by Student’s t-test. Differences were considered statistically significant if p < 0.05.

Results and discussion

The effects of JZLG on the serum enzymes were investigated and the results are given in . It is well known that CCl4 is used as a hepatotoxic agent in various animals (CitationGopal & Sengottuvelu, 2008). The administration of CCl4 to mice produced hepatotoxicity, showed by a significant increase in the serum levels of ALT and AST in comparison to the control group. JZLG caused a significant decrease in the serum enzymes ALT and AST when compared to the CCl4 group. The standard drug, bifendate (biphenyldicarboxylate, 200 mg/kg, p.o.), also exhibited similar significant results. There were no significant differences in body weight and relative liver weight between all groups (). In the preliminary acute toxicity study, the JZLG test did not show any mortality up to 32 g/kg (equivalent to 250 times the clinical dose, the maximum administration volume).

Table 1. Effect of JZLG on CCl4 induced liver damage in mice.

Table 2. Body weight and relative liver weight of mice.

On the basis of the results obtained, it can be concluded that JZLG seems to possess hepatoprotective activity in mice. No toxic symptom or mortality was observed in the 48 h study in mice. These results seem to support the traditional use of this prescription against hepatotoxicity.

Declaration of interest: This work was supported by grant 2006Y002A (to Q.Z.) from the Shanghai Municipal Health Bureau.

References

  • Asl MN, Hosseinzadeh H (2008): Review of pharmacological effects of. Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22: 709–724.
  • Chu CY, Lee MJ, Liao CL, Lin WL, Yin YF, Tseng TH (2003): Inhibitory effect of hot-water extract from dried fruit of Crataegus pinnatifida on low-density lipoprotein (LDL) oxidation in cell and cell-free systems. J Agric Food Chem 51: 7583–7588.
  • Gopal N, Sengottuvelu S (2008): Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats. Fitoterapia 79: 24–26
  • Ibrahim M, Khaja MN, Aara A, Khan AA, Habeeb MA, Devi YP, Narasu ML, Habibullah CM (2008): Hepatoprotective activity of Sapindus mukorossi and Rheum emodi extracts: In vitro and in vivo studies. World J Gastroenterol 14: 2566–2571.
  • Kang SJ, Lee YJ, Kim BM, Kim YJ, Woo HD, Jeon HK, Chung HW (2008): Effect of Bupleuri Radix extracts on the toxicity of 5-fluorouracil in HepG2 hepatoma cells and normal human lymphocytes. Basic Clin Pharmacol Toxicol 103: 305–313.
  • Koo BS, Kwon TS, Kim CH (2004): Salviae miltiorrhizae radix inhibits superoxide generation by activated rat microglias and mimics the action of amphetamine on in vitro rat striatal dopamine release. Neurochem Res 29: 1837–1845.
  • Pan SY, Yang R, Dong H, Yu ZL, Ko KM (2006): Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. Eur J Pharmacol 552: 170–175.
  • Zhao P, Su G, Xiao X, Hao E, Zhu X, Ren J (2008): Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis. Toxicol Lett 182: 29–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.